Clinical Trial Diversity
We are committed to ensuring that the development of our
medicines reflects the diverse populations we serve.
Envisioning a More Inclusive Future
Our Focus Goes Beyond Medicine
At Gilead, we address societal barriers to care that have excluded people from underrepresented and disproportionately impacted communities from taking part in clinical research.
A New Era of Trust
Our goal is to forge a path that is truly inclusive, fostering a new era of trust by working alongside the community to co-create solutions that effectively address inequities in clinical research.
An Open Invitation to Reshape Clinical Trials
Through open dialogue, partnerships, and a commitment to raise awareness, we aim to remove misconceptions, systemic barriers, and cultivate an environment where participation in clinical trials is a more positive experience.
Gilead's Vision is To Create a
Healthier World for All People
Inclusion is one of Gilead’s core values because it helps us understand
how our treatments will uniquely affect every population. We are actively
working to include a diverse group of participants across all clinical trials.
"Gilead's legacy of putting patients first resonates deeply with me. We're not just enrolling participants; we're building a network of support and understanding. By embracing diversity in clinical trials, we're
not only advancing medical science; we're rewriting a story of equity, one patient at a time."
Stacey Bledsoe, Head of Global Clinical Trial Diversity and Inclusion at Gilead Sciences
Putting Patients First
Considering Patients’ Needs
Our clinical trials prioritize the patient experience and perspectives. By placing patients at the center, we help communities feel seen, heard, and empowered.
Serving a World that’s Bigger Than Us
We believe that by diversifying our research programs, we can better serve all populations, including underrepresented communities who have been disproportionately impacted by many of the diseases we study.
Collaborations that Lead to
Improved Access and Outcomes
Increasing Collaboration to Increase Participation
We collaborate with community-based organizations to identify trial site locations that can best serve underrepresented and disproportionately impacted communities. Removing barriers helps streamline access and increase participation in studies.
Empowering Healthcare Providers
We partner with HCPs who serve underrepresented and disproportionately impacted communities, providing them with resources, training, and support to engage in clinical trials and facilitate access for patients.
Improving Health Equity
Partnering with Community
We develop strategies tailored to improve trial access and participation through our engagements with academic institutions, community organizations, patient advocacy groups, and local healthcare providers.
Advocating for Policy Change
We advocate for policies that advance health equity by addressing barriers and improving clinical trial access to underrepresented and disproportionally impacted communities.